These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27785115)

  • 1. Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience.
    Callis Duffin K; Bukhalo M; Bobonich MA; Shrom D; Zhao F; Kershner JR; Gill A; Pangallo B; Shuler CL; Bagel J
    Med Devices (Auckl); 2016; 9():361-369. PubMed ID: 27785115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 3, open-label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate-to-severe plaque psoriasis (UNCOVER-A).
    Callis Duffin K; Bagel J; Bukhalo M; Mercado Clement IJ; Choi SL; Zhao F; Gill A; Pangallo B; Shuler C; Mallbris L; Jackson K
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):107-113. PubMed ID: 27500949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration.
    Arora S; Moclair B; Murphy K; Jaffe JS; Kaminetsky JC
    J Sex Med; 2018 Dec; 15(12):1707-1715. PubMed ID: 30393104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device.
    Varunok P; Lawitz E; Beavers KL; Matusow G; Leong R; Lambert N; Bernaards C; Solsky J; Brennan BJ; Wat C; Bertasso A
    Patient Prefer Adherence; 2011; 5():587-99. PubMed ID: 22163158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies.
    Stauffer VL; Sides R; Lanteri-Minet M; Kielbasa W; Jin Y; Selzler KJ; Tepper SJ
    Patient Prefer Adherence; 2018; 12():1785-1795. PubMed ID: 30271122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study.
    Vermeire S; D'heygere F; Nakad A; Franchimont D; Fontaine F; Louis E; Van Hootegem P; Dewit O; Lambrecht G; Strubbe B; Baert F
    Patient Prefer Adherence; 2018; 12():1193-1202. PubMed ID: 30013330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE).
    Paul C; Lacour JP; Tedremets L; Kreutzer K; Jazayeri S; Adams S; Guindon C; You R; Papavassilis C;
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1082-90. PubMed ID: 25243910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis.
    Hudry C; Lebrun A; Moura B; Zinovieva E; Backers O; Herman-Demars H
    Rheumatol Ther; 2017 Jun; 4(1):183-194. PubMed ID: 28243967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis.
    Rho YH; Rychlewska-Hańczewska A; Śliwowska B; Kim TH
    Adv Ther; 2019 Sep; 36(9):2287-2295. PubMed ID: 31372961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Reported Ease-of-Use with a Disposable Autoinjector in Individuals with Migraine.
    Mead J; Dammerman R; Rasmussen S
    Patient Prefer Adherence; 2020; 14():1137-1144. PubMed ID: 32753854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.
    Struemper H; Murtaugh T; Gilbert J; Barton ME; Fire J; Groark J; Fox NL; Roth D; Gordon D
    Clin Pharmacol Drug Dev; 2016 May; 5(3):208-15. PubMed ID: 27163500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions About Glucagon Delivery Devices for Severe Hypoglycemia: Qualitative Research With Patients, Caregivers, and Acquaintances.
    Bajpai SK; Cambron-Mellott MJ; Peck E; Poon JL; Wang Q; Mitchell BD; Babrowicz J; Child CJ; Raibulet NK; Beusterien K
    Clin Ther; 2019 Oct; 41(10):2073-2089.e6. PubMed ID: 31526655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis.
    Singer B; Wray S; Miller T; Cascione M; Gupta A; Pardo G; Watsky E; Hayward B; Mercer B; Dangond F
    Mult Scler Relat Disord; 2012 Apr; 1(2):87-94. PubMed ID: 25876936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correct performance of subcutaneous injections in plaque psoriasis: comparison of trained and untrained patients with different application systems in routine clinical care.
    Stenger F; König A; Ochsendorf F; Kaufmann R; Pinter A
    J Dermatolog Treat; 2021 Dec; 32(8):898-906. PubMed ID: 32009495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis.
    Schwarzenbach F; Dao Trong M; Grange L; Laurent PE; Abry H; Cotten J; Granger C
    Patient Prefer Adherence; 2014; 8():199-209. PubMed ID: 24627625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Use of Exenatide Once-Weekly Suspension Autoinjector Among Patients With Type 2 Diabetes Mellitus and Health Care Professionals.
    LaRue S; Springer J; Noderer M; Meehan J; Wysham CH
    J Diabetes Sci Technol; 2019 Mar; 13(2):226-234. PubMed ID: 30234374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
    Spuls PI; Hooft L
    Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study.
    Wray S; Hayward B; Dangond F; Singer B
    Expert Opin Drug Deliv; 2018 Feb; 15(2):127-135. PubMed ID: 29206056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis.
    Gordon KB; Leonardi CL; Lebwohl M; Blauvelt A; Cameron GS; Braun D; Erickson J; Heffernan M
    J Am Acad Dermatol; 2014 Dec; 71(6):1176-82. PubMed ID: 25242558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design Development of the SMARTCLIC
    Berman K; Moss S; Holden-Theunissen B; Satou N; Okada K; Latymer M; Antalfy A
    Adv Ther; 2023 Jul; 40(7):3070-3086. PubMed ID: 37199860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.